ALPS Advisors’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$399K Sell
4,011
-3
-0.1% -$391 ﹤0.01% 951
2025
Q4
$488K Buy
4,014
+34
+0.9% +$4.27K ﹤0.01% 753
2025
Q3
$447K Buy
+3,980
New +$466K ﹤0.01% 812
2022
Q3
Sell
-10,472
Closed -$329K 1188
2022
Q2
$329K Buy
+10,472
New +$279K ﹤0.01% 728

Other funds holding TMDX

ALPS Advisors's TMDX Position: Q1 2026 in Review

ALPS Advisors reduced its Transmedics (TMDX) stake by 0.07% in Q1 2026, selling an estimated $391 and leaving 4,011 shares worth $399K. The position accounts for ﹤0.01% of the portfolio, ranked #951.

ALPS Advisors first reported a position in TMDX in Q2 2022 and has held it in 4 quarters since. The position peaked at $488K in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • ALPS Advisors held 4,011 shares of Transmedics worth $399K as of Q1 2026.
  • ALPS Advisors sold 3 Transmedics shares in Q1 2026, an estimated $391.
  • Transmedics made up ﹤0.01% of ALPS Advisors's portfolio in Q1 2026, its #951 holding.
  • ALPS Advisors first reported a position in Transmedics in Q2 2022 and has held it in 4 quarters since.
  • ALPS Advisors's Transmedics position peaked at $488K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.